Original Article

You have full text access to this OnlineOpen article

p53-induced RING-H2 protein, a novel marker for poor survival in hepatocellular carcinoma after hepatic resection

  1. Xiao-Min Wang MD†,
  2. Lian-Yue Yang MD, PhD†,‡,*,
  3. Lei Guo MD,
  4. Chun Fan,
  5. Fan Wu MD

Article first published online: 23 JUN 2009

DOI: 10.1002/cncr.24494

Issue

Cancer

Cancer

Volume 115, Issue 19, pages 4554–4563, 1 October 2009

Additional Information

How to Cite

Wang, X.-M., Yang, L.-Y., Guo, L., Fan, C. and Wu, F. (2009), p53-induced RING-H2 protein, a novel marker for poor survival in hepatocellular carcinoma after hepatic resection. Cancer, 115: 4554–4563. doi: 10.1002/cncr.24494

Author Information

  1. Liver Cancer Laboratory, Department of Surgery, Xiangya Hospital, Central South University, Changsha City, People's Republic of China

  1. †

    The first 2 authors contributed equally to this work.

  2. ‡

    Fax: (011) 86-731-4327332

*Liver Cancer Laboratory, Department of Surgery, Xiangya Hospital, Central South University, Xiangya Road 87, Changsha City 410008, Hunan, P. R. China

Publication History

  1. Issue published online: 17 SEP 2009
  2. Article first published online: 23 JUN 2009
  3. Manuscript Revised: 12 FEB 2009
  4. Manuscript Accepted: 12 FEB 2009
  5. Manuscript Received: 30 SEP 2008

Funded by

  • National Key Technology R&D Program of China. Grant Numbers: 2001BA703B04, 2004BA703B02
  • National Basic Research Program of China. Grant Number: 2004CB720303
  • National Natural Science Foundation for Distinguished Young Scholars of China. Grant Number: 30328028
  • National High Technology Research and Development Program of China. Grant Number: 2006AA02Z4B2

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (325K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Feng Fang, Lianyue Yang, Yiming Tao, Wei Qin, FBI-1 promotes cell proliferation and enhances resistance to chemotherapy of hepatocellular carcinoma in vitro and in vivo, Cancer, 2012, 118, 1
    Direct Link:
  2. 2
    Yong-Sam Jung, Yingjuan Qian, Xinbin Chen, Pirh2 RING-finger E3 ubiquitin ligase: Its role in tumorigenesis and cancer therapy, FEBS Letters, 2012, 586, 10, 1397

    CrossRef

  3. You have free access to this content3
    Zhihao Wang, Bo Yang, Lanlan Dong, Biwen Peng, Xiaohua He, Wanhong Liu, A novel oncoprotein Pirh2: rising from the shadow of MDM2, Cancer Science, 2011, 102, 5
    Direct Link:
  4. 4
    Xiaodong Huang, Xiaoli Qian, Chun Cheng, Song He, Linlin Sun, Qing Ke, Li Zhang, Xia Pan, Fei He, Qiuhong Wang, Jie Meng, Runzhou Ni, Aiguo Shen, Expression of Pirh2, a p27Kip1 ubiquitin ligase, in hepatocellular carcinoma: correlation with p27Kip1 and cell proliferation, Human Pathology, 2011, 42, 4, 507

    CrossRef

  5. 5
    Gang Wu, Meiqian Sun, Liping Zhang, Juan Zhou, Yi Wang, Keke Huo, A novel hPirh2 splicing variant without ubiquitin protein ligase activity interacts with p53 and is down-regulated in hepatocellular carcinoma, FEBS Letters, 2010, 584, 13, 2772

    CrossRef

View Full Article (HTML) Get PDF (325K)